EPISODE · Jan 30, 2023 · 22 MIN
The DCP Study: HCTZ vs Chlorthalidone
from CEimpact Podcast · host CEimpact
Hydrochlorothiazide is the go-to thiazide for hypertension control despite better data for chlorthalidone. Join host Geoff Wall as he evaluates the new randomized controlled study to determine what is the best thiazide.The GameChangerSeveral pharmacologic differences exist between hydrochlorothiazide and chlorthalidone. The new DCP Study did not find any differences in cardiovascular outcomes.Show Segments00:00 - Introductions02:20 - History of HCTZ vs Chlorthalidone05:26 - The Diuretic Comparison Project: HCTZ vs Chlorthalidone12:27 - The GameChanger: DCP Results19:48 - Connecting to Practice: Choosing Between the Two21:47 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferences and ResourcesChlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.Redeem your CPE or CME hereCPE (Pharmacist)CME (Physician)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the pharmacologic differences of hydrochlorothiazide and chlorthalidone2. Apply the results of the DCP Study to clinical practice0.05 CEU/0.5 HrUAN: 0107-0000-23-025-H01-PInitial release date: 01/30/2023Expiration date: 01/30/2024Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
NOW PLAYING
The DCP Study: HCTZ vs Chlorthalidone
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m